Department of Medicine, Division of Cardiovascular Medicine; UMass Center for Clinical and Translational Science; Program in Molecular Medicine
Clinical Trials | Infectious Disease | International Business | International Public Health | Technology and Innovation | Virus Diseases
The 2020s began with a rare coronavirus (COVID-19) disaster, which led to a pandemic-induced recession and Great Lockdown. In response, there has been a worldwide mobilization of resources to detect, treat, and cure the virus. Some policymakers are advocating for the repatriation of globally distributed healthcare know-how. Without a cure for COVID-19, the ambiguity concerning how coronavirus-related policies will impact international business remains unclear. Through a multi-method approach, our study sheds light on two key healthcare industry trends: decentralization and deglobalization of clinical trials. We offer actionable strategies to not only mitigate these challenges, but also to take advantage of their new opportunities.
clinical trials, covid-19, decentralization, deglobalization, emerging technologies, healthcare, UMCCTS funding
Rights and Permissions
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY-4.0). View this license’s legal deed at http://creativecommons.org/licenses/by/4.0 and legal code at http://creativecommons.org/licenses/by/4.0/legalcode for more information.
DOI of Published Version
Dunlap D, Santos RS, McManus DD, Buchholz BO, Hafer NS, Picard M. New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown. AIB Insights. 2020 Nov 3;20(3):10.46697/001c.17692. doi: 10.46697/001c.17692. PMID: 34413924; PMCID: PMC8372191. Link to article on publisher's site
Dunlap D, Santos RS, McManus DD, Buchholz BO, Hafer NS, Picard M. (2020). New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown. COVID-19 Publications by UMMS Authors. https://doi.org/10.46697/001c.17692. Retrieved from https://escholarship.umassmed.edu/covid19/286
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.